Malarone Dosing for Malaria
Prophylaxis Dosing
For malaria prophylaxis, adults and children >40 kg should take one adult-strength tablet (250 mg atovaquone/100 mg proguanil) once daily, starting 1-2 days before travel, continuing throughout exposure, and for 7 days after leaving the malaria-endemic area 1, 2.
Weight-Based Pediatric Dosing for Prophylaxis:
- 11-20 kg: 1 pediatric tablet (62.5/25 mg) daily
- 21-30 kg: 2 pediatric tablets daily
- 31-40 kg: 3 pediatric tablets daily
- >40 kg: 1 adult tablet daily
Key Prophylaxis Principles:
- Begin 1-2 days before entering endemic area (not 1 week like older regimens)
- Take with food or milk to enhance absorption 2-3 fold 3
- Continue for only 7 days after departure (shorter than other antimalarials due to causal prophylactic activity against liver stages) 1, 2
- Prophylactic efficacy is 95-100% against P. falciparum, including drug-resistant strains 1
Treatment Dosing
For treatment of uncomplicated P. falciparum malaria, adults and children >40 kg should take 4 adult-strength tablets (total 1000 mg atovaquone/400 mg proguanil) once daily for 3 consecutive days 4, 5, 6.
Weight-Based Pediatric Treatment Dosing:
- 11-20 kg: 1 adult tablet daily × 3 days
- 21-30 kg: 2 adult tablets daily × 3 days
- 31-40 kg: 3 adult tablets daily × 3 days
- >40 kg: 4 adult tablets daily × 3 days
Treatment Considerations:
- Cure rate >98% for uncomplicated falciparum malaria 5, 6
- Must be taken with fatty food or drink to optimize absorption 4
- Not recommended as first-line for treatment - artemisinin-based combination therapies (ACTs) like artemether-lumefantrine or dihydroartemisinin-piperaquine are preferred due to faster parasite clearance 4
- Atovaquone-proguanil is considered second-line/alternative treatment when ACTs are contraindicated or unavailable 4
Important Clinical Caveats:
Absorption is critical: Atovaquone is highly lipophilic with poor water solubility. Taking with fatty food increases bioavailability 2-3 fold for AUC and 5-fold for peak concentration 3. Without food, treatment may fail.
Post-travel duration controversy: While current guidelines mandate 7 days post-exposure prophylaxis, emerging evidence suggests shorter regimens may be effective due to causal prophylactic activity 7, 8, 9. However, the quality and sample size of studies supporting the standard 7-day regimen significantly outweigh those supporting abbreviated regimens 8. Stopping early risks atovaquone monotherapy (proguanil has 12-15 hour half-life vs 2-3 days for atovaquone) and potential resistance selection 8. Continue the full 7 days post-exposure until definitive trials prove otherwise.
Contraindications: Avoid in severe renal impairment (CrCl <30 mL/min), pregnancy (though some guidelines permit use), and for prophylaxis in children <11 kg 1.
Common adverse effects: Headache, abdominal pain, nausea, vomiting, diarrhea - but significantly fewer neuropsychiatric effects than mefloquine and fewer GI effects than chloroquine-proguanil combinations 1.